Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGaming Realms Regulatory News (GMR)

Share Price Information for Gaming Realms (GMR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 36.20
Bid: 35.80
Ask: 36.20
Change: 0.30 (0.84%)
Spread: 0.40 (1.117%)
Open: 36.30
High: 36.80
Low: 35.80
Prev. Close: 35.90
GMR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Decon JV Agreement

16 Sep 2010 07:00

RNS Number : 7849S
Pursuit Dynamics PLC
16 September 2010
 



16 September 2010

 

Pursuit Dynamics PLC

("PDX" or "the Company")

 

PDX teams up with NNL for nuclear market joint venture

 

PDX today announces that it has entered into an agreement to establish a joint venture with the UK's National Nuclear Laboratory ("NNL") to jointly develop, produce and market products for the global nuclear market.

 

The joint venture will be owned 60% by PDX and 40% by NNL and will be established by the end of November this year pending approval by NNL's shareholders. There will be no up front costs to PDX in establishing the joint venture and the Company expects that revenues will materialise within the first 18 months.

 

The joint venture combines NNL's experience as a world leader in the provision of nuclear technology services and PDX's best in class technology. The new product range launched by the joint venture will focus immediately on addressing the enormous legacy decommissioning issues and future decontamination potential of the global nuclear industry.

 

The nuclear industry estimates that the cost of decommissioning the UK's legacy nuclear sites is expected to be £73.6 billion, whilst the global cost is estimated to be over £300bn. When combined with the estimated cost of decontaminating new build nuclear reactors, the industry estimates the global market to be worth in excess of £600 billion.

 

Commenting on the announcement, Roel Pieper, CEO of PDX, said:

 

"NNL is the outstanding counter party for PDX in the field of nuclear decontamination. It represents the centre of expertise in the UK nuclear industry and through its extensive network of existing contracts and commercial relationships offers the joint venture an excellent path to the global market."

 

Mark Sharpe, Strategic Business Development at NNL, said:

 

"NNL is delighted to sign this agreement with PDX to introduce its unique and exciting technology to the UK civil nuclear decommissioning market. We consider the technology to have numerous immediate applications within the decontamination field, developing rapidly across wider nuclear fuel cycle applications. The opportunity to reduce radioactive waste volumes significantly through smarter and innovative technology has the potential to bring huge cost savings to the UK nuclear clean up programme. It will also promote leading edge environmental management best practice and enable the UK to penetrate the global market."

 

- Ends -

 

 

For Further Information, please contact:

 

PDX

Roel Pieper, Chief Executive

Tel: +44 (0)1480 422050

Donald Bell, Chief Financial Officer

National Nuclear Laboratory

David Healey, Financial & Commercial Director

Mark Sharpe, Strategic Business Development

Tel +44 (0) 1925 289969

FD

Ben Foster, Marc Cohen

Tel: +44 (0) 20 7831 3113

 

 

Cenkos Securities plc

Ian Soanes, Max Hartley

Tel: +44 (0)20 7397 8924

Mirabaud Securities LLP

Rory Scott

Tel: +44 (0) 20 7878 3360

 

Notes to Editors

 

About PDX

 

- PDX (AIM: PDX) owns and commercialises the PDX Atomiser and Reactor technologies that enable significant reductions in energy usage, process acceleration and result enhancement for a wide range of industrial processes and applications.

 

- The PDX business model is now organized into four Lines of Business - Bio-fuels, Brewing and Food, Decontamination and Fire Suppression.

 

- PDX is headquartered in Huntingdon, UK with an office in Norwalk, Connecticut, USA.

 

- Further information is available at the Company's website: www.pdx.biz 

 

- Publication quality photographs are available from FD.

 

 

About NNL

 

- The UK's National Nuclear Laboratory (NNL) provides an extensive and integrated range of technology services and solutions based on a powerful combination of knowledge, experience and unique facilities. Products and services are offered to customers across a diverse range of areas including homeland security and non-proliferation, nuclear science and environmental management.

 

- NNL has seven locations around the UK, including Sellafield, Warrington and Harwell.

 

- Further information is available at NNL's website: www.nnl.co.uk 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRGGURPBUPUPPA
Date   Source Headline
2nd Apr 20247:01 amRNSInvestor Presentation
2nd Apr 20247:00 amRNSAnnual Results 2023
27th Mar 20244:05 pmRNSTotal Voting Rights and Share Capital
5th Feb 20247:00 amRNSPre-Close Trading Update
30th Jan 20244:00 pmRNSBlock Listing Six Monthly Return
30th Jan 20244:00 pmRNSTotal Voting Rights and Share Capital
30th Nov 20237:00 amRNSTotal Voting Rights and Share Capital
28th Sep 20237:00 amRNSInvestor Presentation
12th Sep 20237:00 amRNSInterim Results
14th Aug 20237:00 amRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20234:59 pmRNSDirector/PDMR Shareholding
28th Jul 20232:00 pmRNSTotal Voting Rights and Share Capital
28th Jul 20232:00 pmRNSBlock Listing Six Monthly Return
27th Jul 20237:00 amRNSPre-Close Trading Update
30th Jun 20233:02 pmRNSTotal Voting Rights and Share Capital
31st May 202312:35 pmRNSResult of AGM
3rd Apr 20237:00 amRNSAnnual Results 2022
1st Feb 20237:00 amRNSPre-Close Trading Update and Board Changes
30th Jan 20231:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
24th Jan 20237:00 amRNSGaming Realms to Introduce Tetris® Slingo®
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSAppointment of Joint Broker
12th Dec 20227:00 amRNSRepayment of Loan
25th Nov 20224:40 pmRNSSecond Price Monitoring Extn
25th Nov 20224:35 pmRNSPrice Monitoring Extension
1st Nov 20227:00 amRNSBoard Appointment
25th Oct 20227:00 amRNSGaming Realms launches content in Connecticut
14th Oct 20224:40 pmRNSSecond Price Monitoring Extn
14th Oct 20224:36 pmRNSPrice Monitoring Extension
20th Sep 20227:00 amRNSInterim Results
16th Sep 20227:00 amRNSRetail Investor Conference Call
22nd Aug 20224:41 pmRNSSecond Price Monitoring Extn
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSNotice of Results
28th Jul 20222:14 pmRNSBLOCK LISTING SIX MONTHLY RETURN
15th Jul 20224:41 pmRNSSecond Price Monitoring Extn
15th Jul 20224:35 pmRNSPrice Monitoring Extension
12th Jul 20223:45 pmRNSDirector/PDMR Shareholding
11th Jul 20224:35 pmRNSPrice Monitoring Extension
23rd Jun 202212:40 pmRNSDirector/PDMR Shareholding
21st Jun 20227:00 amRNSGaming Realms granted Licence in Connecticut
8th Jun 202212:03 pmRNSResult of AGM
12th May 20224:41 pmRNSSecond Price Monitoring Extn
12th May 20224:35 pmRNSPrice Monitoring Extension
11th May 20227:00 amRNSDirector/PDMR Shareholding
26th Apr 20227:00 amRNSAnnual Results 2021
6th Apr 20227:00 amRNSGaming Realms launches content in Ontario
31st Mar 20222:25 pmRNSTotal Voting Rights and Share Capital

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.